Syndrome News and Research

RSS

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Researchers investigated the clinical, histopathological, imaging, and serological characteristics of post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC) in patients with mild COVID-19.

5 Dec 2022

Immunopeptidome characters of human CoV-OC43-infected cells

Researchers explored T-cell epitopes derived from human seasonal coronavirus OC43.

5 Dec 2022

Does irritable bowel syndrome result from gravity?

New research discussed the hypothesis that irritable bowel syndrome (IBS) may result from gravity.

5 Dec 2022

Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level

Researchers evaluated compositional and structural pulmonary alterations in PASC tissues.

5 Dec 2022

Comparison of blood plasma protein expression in mild, moderate, and severe COVID-19 identifies novel disease severity biomarkers

Researchers evaluated blood plasma proteins to identify new targets for COVID-19 treatment approaches and prevent complications associated with severe illness.

5 Dec 2022

How did the seasonal patterns of RSV infections in 2022 compare with those from other COVID-19 pandemic and pre-pandemic years?

Researchers assessed the impact of the COVID-19 pandemic on the seasonal patterns of RSV infections among young children residing in the US.

5 Dec 2022

Exploring effects of COVID-19 pandemic on neurodevelopment and mental health in adolescents

Researchers examined the impact of the coronavirus disease 2019 (COVID-19) pandemic on adolescents' neurodevelopment and mental health.

5 Dec 2022

Impact of COVID-19 booster vaccination and breakthrough infection

Researchers assessed the protection elicited after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccination or a breakthrough infection against SARS-CoV-2 Omicron variant infection.

5 Dec 2022

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers developed an mRNA technology-based vaccine candidate against the monkeypox virus and evaluated its immunogenicity in animal models.

5 Dec 2022

Study estimates the epidemiological impact of a COVID-19 testing-related incident at a surge laboratory in the UK

Researchers investigated the epidemiological impact of an incident at a laboratory in the UK.

5 Dec 2022

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Researchers investigated the potential of the CAPN2 molecule as a therapeutic target against SARS-CoV-2.

5 Dec 2022

COVID-19 pandemic caused rapid brain aging in adolescents

Researchers assess how the COVID-19 pandemic affected the neurological development of young adults.

4 Dec 2022

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

In a new study, researchers assessed the neurodevelopment in preschool-aged Zika-exposed children without congenital Zika syndrome.

2 Dec 2022

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

researchers compared the post-coronavirus disease complaints and symptoms in individuals infected with the SARS-CoV-2 Omicron variant with those in individuals with Delta variant infections to understand whether the long-term complaints after Omicron infections are similar to those in infections with other SARS-CoV-2 variants.

2 Dec 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the SARS-CoV-2 Omicron variant.

2 Dec 2022

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

A recent Clinical and Translational Medicine study utilized several published public datasets to evaluate the biological characteristics associated with the ubiquitination of patients infected with SARS-CoV-2.

2 Dec 2022

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Researchers compared seropositive and seronegative children between the ages of six months and 17 years to assess the risk factors and prevalence of persistent symptoms of post-COVID syndrome.

2 Dec 2022

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Researchers investigated passive immunization of the fetus and neonates by evaluating the antibody responses elicited by primary and booster doses of maternal SARS-CoV-2 vaccination.

2 Dec 2022

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

Syndrome News and Research

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Immunopeptidome characters of human CoV-OC43-infected cells

Does irritable bowel syndrome result from gravity?

Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level

Comparison of blood plasma protein expression in mild, moderate, and severe COVID-19 identifies novel disease severity biomarkers

How did the seasonal patterns of RSV infections in 2022 compare with those from other COVID-19 pandemic and pre-pandemic years?

Exploring effects of COVID-19 pandemic on neurodevelopment and mental health in adolescents

Impact of COVID-19 booster vaccination and breakthrough infection

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Study estimates the epidemiological impact of a COVID-19 testing-related incident at a surge laboratory in the UK

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

COVID-19 pandemic caused rapid brain aging in adolescents

Exploring neurodevelopment among Zika virus-exposed children without Zika syndrome

SARS-CoV-2 Omicron infections pose long-COVID risks despite reduced severity

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

The effect of ubiquitination on SARS-CoV-2 infection and patient prognosis

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News